Isogen has made the first phase launch of its contract aseptic manufacturing facility in Delaware. Isogen’s Phase I facility will accommodate GMP vial and syringe filling, ranging in fill size up to 4,000 units per shift in fully segregated, isolator-based fill lines in a potent capable facility. Isolator-based lyo-capacity is planned for later in 2009. The company contends that its facility will enable customers to “plan and execute the supply of integrated sterile clinical and s...